Sector
1090 stories · page 34 of 55
“We are excited to welcome Dr Jetly to our board of directors and look forward to leveraging his expertise and insights in mental health as we continue to expand the services offered to our patients,” Pathway Health CEO Ken Yoon said
"We've seen improved outcomes first-hand from ketamine treatment in our clinics and in our clinical trials. Adding digital telehealth capabilities through KetaMD's mobile platform strengthens our position to lead the medical use of evidence
The company said it intends to use the available proceeds for general working capital and potential future acquisition purposes
The medical research company, which provides ketamine treatments for depression and related disorders, said revenue came in at C$1.49 million for fiscal 2022 compared to revenue of C$1.008 million in the year to March 31, 2021
This is the third acquisition that Irwin Naturals Emergence has completed in the past five months in an effort to build a national chain of mental health clinics providing psychedelic treatment using ketamine
The medical research company said both roles will be integral to executing the expansion of Braxia's clinical footprint, the rollout and expansion of novel ketamine and psilocybin therapy offerings, and the potential commercialization of fu
Self-care product developer still wary of supply chain issues in Chinese market
Under the agreement, KGK will perform research services, including the development of the clinical trial protocol, preparations towards the phase II clinical trials, data management and validation, statistical analysis and drafting of the f
IQ-AI said it is looking to accelerate the adoption of IB Clinic for healthcare providers through global networks
"This notice of allowance reaffirms the strength of Mindset's IP position and facilitates our ongoing development of Family 2, a highly differentiated asset in our mission to help patients with unmet needs via the discovery of optimized psy
“We've strategically staged building materials on site over the past three months to build a world-class cultivation facility on an expedited timeline, with a full campus project planned for future phases,” said the company's co-CEO Larry S
With the increase in technology and breakthroughs occurring in vision therapy, the company said it will focus on the redevelopment, update, and improvement of its Binovi Pro and Binovi Coach software and platform to make them more accessibl
Here’s Proactive Australia’s round-up of the top local financial stories of the day, with helpful links taking you directly to the news.
Results indicate that CimetrA may have a wider-ranging application beyond the treatment of the symptoms of COVID-19, which has been the primary focus of clinical trials to date.
Oncogeni was founded by professor Sir Martin Evans, who was awarded the prize in 2007
“We believe the strength of our brand will reduce the mental barrier for many people when they engage with this type of therapy,” said the company's CEO Klee Irwin
"Natalie is an outstanding addition to our Wellbeing team, having an exceptional record of leading successful marketing programs in her previous positions and will be able to focus attention on highlighting our high-quality assets and longe
The company noted that this is the eighth ketamine clinic it has added to its growing portfolio, which now covers four states, made up of acquired clinics and clinics under definitive agreements
"2022 will be foundational year that will set the stage for Wellbeing to execute on its strategy in the future," said Najla Guthrie, Wellbeing's chief executive officer
"This clinically meaningful change has impact on this population of patients with self-reported knee pain," said Dr Mal Evans, chief scientific officer at KGK Science
